131 related articles for article (PubMed ID: 32758055)
1. Impact of Rhabdomyosarcoma Treatment Modalities by Age in a Population-Based Setting.
Ferrari A; Bernasconi A; Bergamaschi L; Botta L; Andreano A; Castaing M; Rugge M; Bisogno G; Falcini F; Sacerdote C; Tagliabue G; Michiara M; Cirilli C; Barchielli A; Filiberti RA; Vitale MF; Tumino R; Stracci F; Chiaravalli S; Casanova M; Gasparini P; Milano GM; Gatta G; Trama A
J Adolesc Young Adult Oncol; 2021 Jun; 10(3):309-315. PubMed ID: 32758055
[No Abstract] [Full Text] [Related]
2. [Clinical and prognostic analysis of single-center multidisciplinary treatment for rhabdomyosarcoma in children].
Xu N; Duan C; Jin M; Zhang DW; Su Y; Yu T; He LJ; Fu LB; Zeng Q; Wang HM; Zhang WP; Ni X; Ma XL
Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):767-773. PubMed ID: 31594063
[No Abstract] [Full Text] [Related]
3. Rhabdomyosarcoma in adults: analysis of treatment modalities in a prospective single-center series.
Bergamaschi L; Bertulli R; Casanova M; Provenzano S; Chiaravalli S; Gasparini P; Collini P; Sangalli C; Gandola L; Diletto B; Morosi C; Fiore M; Massimino M; Ferrari A
Med Oncol; 2019 May; 36(7):59. PubMed ID: 31104202
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes of pediatric patients with newly diagnosed rhabdomyosarcoma treated by two consecutive protocols - A single institution report in Taiwan.
Chou SW; Chang HH; Lu MY; Yang YL; Lin DT; Lin KH; Jou ST
J Formos Med Assoc; 2019 Jan; 118(1 Pt 2):332-340. PubMed ID: 29903549
[TBL] [Abstract][Full Text] [Related]
5. Adult rhabdomyosarcoma survival improved with treatment on multimodality protocols.
Gerber NK; Wexler LH; Singer S; Alektiar KM; Keohan ML; Shi W; Zhang Z; Wolden S
Int J Radiat Oncol Biol Phys; 2013 May; 86(1):58-63. PubMed ID: 23414767
[TBL] [Abstract][Full Text] [Related]
6. Biliary tract rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Associazione Italiana Ematologia Oncologia Pediatrica.
Perruccio K; Cecinati V; Scagnellato A; Provenzi M; Milano GM; Basso E; Manzitti C; Cecchetto G; Alaggio R; Di Martino M; Schiavetti A; Melchionda F; Affinita MC; Chiaravalli S; Miglionico L; Balter R; Tamburini A; Bisogno G; Ferrari A
Tumori; 2018 Jun; 104(3):232-237. PubMed ID: 29192742
[TBL] [Abstract][Full Text] [Related]
7. Evolving Services for Adolescents with Cancer in Italy: Access to Pediatric Oncology Centers and Dedicated Projects.
Ferrari A; Quarello P; Mascarin M; Milano GM; Tornesello A; Bertolotti M; Spinelli M; Ballotta P; Read Borghi M; Maule M; Mosso ML; Merletti F; Zecca M; Pession A
J Adolesc Young Adult Oncol; 2020 Apr; 9(2):196-201. PubMed ID: 31747324
[No Abstract] [Full Text] [Related]
8. Adolescents with Cancer in Italy: Improving Access to National Cooperative Pediatric Oncology Group (AIEOP) Centers.
Ferrari A; Rondelli R; Pession A; Mascarin M; Buzzoni C; Mosso ML; Maule M; Barisone E; Bertolotti M; Clerici CA; Jankovic M; Fagioli F; Biondi A
Pediatr Blood Cancer; 2016 Jun; 63(6):1116-9. PubMed ID: 26914476
[TBL] [Abstract][Full Text] [Related]
9. Risk-directed therapy for childhood acute lymphoblastic leukemia. Results of the Associazione Italiana Ematologia Oncologia Pediatrica '82 studies.
Vecchi V; Aricò M; Basso G; Ceci A; Madon E; Mandelli F; Masera G; Massimo L; Pession A; Zanesco L
Cancer; 1993 Oct; 72(8):2517-24. PubMed ID: 8402470
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of disease classified as stage III in Wilms tumor: a report from the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP).
Spreafico F; Gandola L; D'Angelo P; Terenziani M; Collini P; Bianchi M; Provenzi M; Indolfi P; Pession A; Nantron M; Di Cataldo A; Marchianò A; Catania S; Fossati Bellani F; Piva L;
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):348-54. PubMed ID: 21075548
[TBL] [Abstract][Full Text] [Related]
11. Rhabdomyosarcoma in adolescents: a report from the AIEOP Soft Tissue Sarcoma Committee.
Bisogno G; Compostella A; Ferrari A; Pastore G; Cecchetto G; Garaventa A; Indolfi P; De Sio L; Carli M
Cancer; 2012 Feb; 118(3):821-7. PubMed ID: 21751206
[TBL] [Abstract][Full Text] [Related]
12. Good steroid response in vivo predicts a favorable outcome in children with T-cell acute lymphoblastic leukemia. The Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP).
Aricò M; Basso G; Mandelli F; Rizzari C; Colella R; Barisone E; Zanesco L; Rondelli R; Pession A; Masera G
Cancer; 1995 Apr; 75(7):1684-93. PubMed ID: 8826928
[TBL] [Abstract][Full Text] [Related]
13. Prognostic relevance of early radiologic response to induction chemotherapy in pediatric rhabdomyosarcoma: A report from the International Society of Pediatric Oncology Malignant Mesenchymal Tumor 95 study.
Vaarwerk B; van der Lee JH; Breunis WB; Orbach D; Chisholm JC; Cozic N; Jenney M; van Rijn RR; McHugh K; Gallego S; Glosli H; Devalck C; Gaze MN; Kelsey A; Bergeron C; Stevens MCG; Oberlin O; Minard-Colin V; Merks JHM
Cancer; 2018 Mar; 124(5):1016-1024. PubMed ID: 29211298
[TBL] [Abstract][Full Text] [Related]
14. Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study. Associazione Italiana Ematologia Oncologia Pediatrica.
Conter V; Aricò M; Valsecchi MG; Rizzari C; Testi A; Miniero R; Di Tullio MT; Lo Nigro L; Pession A; Rondelli R; Messina C; Santoro N; Mori PG; De Rossi G; Tamaro P; Silvestri D; Biondi A; Basso G; Masera G
Haematologica; 1998 Sep; 83(9):791-9. PubMed ID: 9825576
[TBL] [Abstract][Full Text] [Related]
15. Rhabdomyosarcoma: the experience of the pediatric unit of Kasr El-Aini Center of Radiation Oncology and Nuclear Medicine (NEMROCK) (from January 1992 to January 2001).
Abd El-Aal HH; Habib EE; Mishrif MM
J Egypt Natl Canc Inst; 2006 Mar; 18(1):51-60. PubMed ID: 17237856
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Factors and Treatment Outcomes of Adult Patients With Rhabdomyosarcoma After Multimodality Treatment.
Liu YT; Wang CW; Hong RL; Kuo SH
Anticancer Res; 2019 Mar; 39(3):1355-1364. PubMed ID: 30842169
[TBL] [Abstract][Full Text] [Related]
17. Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group.
Meza JL; Anderson J; Pappo AS; Meyer WH;
J Clin Oncol; 2006 Aug; 24(24):3844-51. PubMed ID: 16921036
[TBL] [Abstract][Full Text] [Related]
18. Teratoma with a malignant somatic component in pediatric patients: the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) experience.
Terenziani M; D'Angelo P; Bisogno G; Boldrini R; Cecchetto G; Collini P; Conte M; De Laurentis T; Ilari I; Indolfi P; Inserra A; Piva L; Siracusa F; Spreafico F; Tamaro P; Lo Curto M
Pediatr Blood Cancer; 2010 Apr; 54(4):532-7. PubMed ID: 20049928
[TBL] [Abstract][Full Text] [Related]
19. Rhabdomyosarcoma in adults. A retrospective analysis of 171 patients treated at a single institution.
Ferrari A; Dileo P; Casanova M; Bertulli R; Meazza C; Gandola L; Navarria P; Collini P; Gronchi A; Olmi P; Fossati-Bellani F; Casali PG
Cancer; 2003 Aug; 98(3):571-80. PubMed ID: 12879475
[TBL] [Abstract][Full Text] [Related]
20. Pediatric rhabdomyosarcoma in Morocco.
Hessissen L; Kanouni L; Kili A; Nachef MN; El Khorassani M; Benjaafar N; Khattab M; El Gueddari Bel K
Pediatr Blood Cancer; 2010 Jan; 54(1):25-8. PubMed ID: 19746454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
